background cytomegaloviru cm reactive previous immunocompet critic ill patient assoc increase mortal hypothesis result virusinduc immunomodul therefore studi effect tempo cours host response biomass pepsi method match cohort studi patient develop day compare one seroposit without cm strong serostatu plasma load determine enzymelink immunoassay realtime polymerase chain reaction respect system interleukin il interferongammainduc protein ip neutrophil lasts receptor antagonist ra measure five time point multiplex immunoassay sequence content ass cultivar mix model result among could control two baseline characters biomass level viremia onset similar group symmetry percentage differ versus decrease ila howe analyst show indeed assoc trend concur indeed chang comparison nonreactiv marker use sorrow clinic endpoint intervene studi value antics therapy electron supplementary mater online version article contain avail author user 